Sound waves and gel may ease wrist pain in breast cancer survivors
NCT ID NCT06538818
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether applying ultrasound with a hyaluronic acid gel to the wrist could help women who developed carpal tunnel syndrome from hormone therapy after mastectomy. Sixty women were split into two groups: one received the ultrasound gel treatment plus standard physical therapy, and the other received only standard therapy. The goal was to see if the gel treatment improved nerve function, pain, grip strength, and daily hand use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- hyaluronic acid-containing gel
- What this could lead to
- If it works, this could offer a non-invasive way to reduce pain and improve hand function for women with carpal tunnel syndrome after breast cancer treatment.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not apply to everyone. The treatment is a short-term addition to standard therapy, not a standalone cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age range between 40-55 years. * Female patients will participate in the study. * All patients will have hormonal therapy at least for 6 weeks. * All patients enrolled to the study will have their informed consent. * Patient referred from physician by carpal tunnel syndrome Exclusion Criteria: * -Marked lymphedema. * Steroid injection for CTS. * Thrombosis propensity. * Cervical radiculopathy. * Brachial plexopathy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three shots, one wrist: which injection best eases carpal tunnel?
- Scalpel vs sound waves: two carpal tunnel surgeries go head to head
- Can carpal tunnel surgery restore more than hand function?
- Does nerve healing keep pace with hand recovery after carpal tunnel surgery?
- Retraining the brain to ease carpal tunnel pain: a new approach put to the test
- Can a Two-Session acupuncture treatment match ten sessions for carpal tunnel?